Stay updated with breaking news from Basket Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Q4 2022 consolidated revenue growth of 14.2% to $21.4 millionFY2022 revenue totaled $80.1 million or growth of ~15%, in line with guidanceFY2023 operating plan to focus on achieving positive Adjusted
Operator: Greetings, and welcome to the Rain Therapeutics Third Quarter Earnings Conference Call. At this time all participants are in a listen-only mode.
Rain Therapeutics Inc. (NASDAQ:NASDAQ:RAIN) Q3 2022 Earnings Conference Call November 10, 2022 5:00 PM ET Company Participants Dan Ferry – LifeSci Advisors Avanish Vellanki – Chief...
Operator Good morning, and thank you for standing by. Welcome to the IMV Inc. first-quarter 2021 conference call. [Operator instructions] I would now like to hand the conference over to Pierre Labbé, chief financial officer. Thank you. Please go ahead. Pierre Labbe -- Chief Financial Officer Thank you, Takke. Good morning, everyone. My name is Pierre Labbé, CFO at IMV, and I'm pleased to welcome you to our clinical and operational update and first-quarter financial results conference call. I'm joined today by Fred Ors, our chief executive officer; and Andrew Hall, our chief business office...
Correspondence: Bing Yuan HK Modern Chinese Medicine R&D Center, Room 2, 7/F Kiu Kin Mansion, 566-568 Nathan Road, Kowloon, Hong Kong Abstract: The rise of precision medicine (PM) has initiated the transition of mainstream medicine from disease-based medicine to personalized medicine, alongside which the US FDA has begun to establish a clinical trial and efficacy evaluation (CTEE) system compatible with personalized medicine based on biological markers. Outside of modern medicine, however, there has always existed a personalized medical system, traditional Chinese medicine (TCM), that is, a p...